When nanotechnology focuses on COVID-19
In face of the coronavirus pandemic, the nanotechnology community has joined forces to provide tools and expertise to COVID-19 research efforts. Long-term experience in drug delivery, nanovaccines, immunoengineering, biosensors and platform technologies positions nanotechnology in a unique place to tackle some of the key issues in preclinical and clinical COVID-19 research
Nature Nanotechnology hosted a Q&A session with Nicole Steinmetz (University of California, San Diego) and Ronit Satchi-Fainaro (Tel Aviv University). Nicole and Ronit presented their work on a COVID-19 vaccine and discussed how nanotechnology can contribute to COVID-19 research, in particular for vaccine development, manufacturing and world-wide distribution.
